We are thrilled to invite you to the biggest pharmaceutical event of the year – CPHI 2023 in Barcelona! 🌍

QUINTA-ANALYTICA as a part of Conscio Group, along with our network of companies:, Gen-Plus GmbH & Co. KG, EL Labs, LVA GmbH and strategic partner DiHeSys – Digital Health Systems GmbH, are looking forward to meeting our current partners and friends, and to establish new collaborations and opportunities.

Come meet with us and explore how our collective expertise can drive innovation in #pharmaceuticalresearch #PharmaInnovation, #Bioanalysis, #ClinicalTrials and #manufacturingprocces.

📅 Date: 24th-26th October
📍 Booth: 4H30

🤝 If you’re interested in meeting with us, mention us in the comments, send us a private message or contact us at info@consciogroup.com or sales@quinta.cz, and we’ll schedule a meeting.

Additional News

  • 4 December 2023

    Our new clinical unit in Ostrava comes to life

    It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.

  • 18 July 2023

    Challenges of a large-scale study of breast cancer

    Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

  • 29 June 2023

    EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

    After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.